AFib patients who are on bloodstream thinning medications are in higher risk of developing dementia A fresh study by researchers at the Intermountain INFIRMARY Cardiovascular Institute in Salt Lake City has found that atrial fibrillation sufferers who are on bloodstream thinning medications are in higher risk of developing dementia if their dosages are not in the perfect recommended range. The study greater than 2,600 AFib individuals found they are significantly more likely to develop dementia when using medicines to prevent blood clots, such as for example warfarin, when their dosing is definitely too high or too low for a protracted period of time buy online .
Airfare and one night’s lodging for Scientific Sessions are also available to the recipients. September 3 The postmark deadline for entries is.. AHA calls for entries in 2010 2010 Howard L. Lewis Achievement Award The American Cardiovascular Association announces the decision for entries for the 2010 Howard L. Lewis Accomplishment Award, the association’s highest honor for health and science reporting. The award was set up in 2000, to identify and honor the career achievements of science, health and medical journalists who have documented the considerable progress made in the fight against heart disease and stroke.